SynthesisClinical lymphoma, myeloma & leukemia2020

Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis.

Hervé Avet-Loiseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.